Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity

被引:150
|
作者
Pavlides, Michael [1 ,2 ,3 ]
Banerjee, Rajarshi [4 ]
Tunnicliffe, Elizabeth M. [1 ]
Kelly, Catherine [4 ]
Collier, Jane [2 ]
Wang, Lai Mun [5 ]
Fleming, Kenneth A. [5 ]
Cobbold, Jeremy F. [2 ,3 ]
Robson, Matthew D. [1 ]
Neubauer, Stefan [1 ,3 ]
Barnes, Eleanor [2 ,3 ,6 ]
机构
[1] Univ Oxford, Oxford Ctr Clin Magnet Resonance Res, Radcliffe Dept Med, Oxford, England
[2] Univ Oxford, Translat Gastroenterol Unit, Oxford, England
[3] Oxford NIHR Biomed Res Ctr, Oxford, England
[4] Perspectum Diagnost, Oxford, England
[5] Oxford Univ Hosp, Dept Histopathol, Oxford, England
[6] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England
关键词
diagnostic accuracy; non-alcoholic steatohepatitis; non-invasive test; sensitivity and specificity; TRANSIENT ELASTOGRAPHY; ADVANCED FIBROSIS; NONINVASIVE DIAGNOSIS; PLASMA CYTOKERATIN-18; STIFFNESS MEASUREMENT; HEPATIC-FIBROSIS; STEATOHEPATITIS; METAANALYSIS; RELAXOMETRY; PROGRESSION;
D O I
10.1111/liv.13284
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & AimsThe diagnosis of non-alcoholic steatohepatitis and fibrosis staging are central to non-alcoholic fatty liver disease assessment. We evaluated multiparametric magnetic resonance in the assessment of non-alcoholic steatohepatitis and fibrosis using histology as standard in non-alcoholic fatty liver disease. MethodsSeventy-one patients with suspected non-alcoholic fatty liver disease were recruited within 1month of liver biopsy. Magnetic resonance data were used to define the liver inflammation and fibrosis score (LIF 0-4). Biopsies were assessed for steatosis, lobular inflammation, ballooning and fibrosis and classified as non-alcoholic steatohepatitis or simple steatosis, and mild or significant (Activity 2 and/or Fibrosis 2 as defined by the Fatty Liver Inhibition of Progression consortium) non-alcoholic fatty liver disease. Transient elastography was also performed. ResultsMagnetic resonance success rate was 95% vs 59% for transient elastography (P<.0001). Fibrosis stage on biopsy correlated with liver inflammation and fibrosis (r(s)=.51, P<.0001). The area under the receiver operating curve using liver inflammation and fibrosis for the diagnosis of cirrhosis was 0.85. Liver inflammation and fibrosis score for ballooning grades 0, 1 and 2 was 1.2, 2.7 and 3.5 respectively (P<.05) with an area under the receiver operating characteristic curve of 0.83 for the diagnosis of ballooning. Patients with steatosis had lower liver inflammation and fibrosis (1.3) compared to patients with non-alcoholic steatohepatitis (3.0) (P<.0001); area under the receiver operating characteristic curve for the diagnosis of non-alcoholic steatohepatitis was 0.80. Liver inflammation and fibrosis scores for patients with mild and significant non-alcoholic fatty liver disease were 1.2 and 2.9 respectively (P<.0001). The area under the receiver operating characteristic curve of liver inflammation and fibrosis for the diagnosis of significant non-alcoholic fatty liver disease was 0.89. ConclusionsMultiparametric magnetic resonance is a promising technique with good diagnostic accuracy for non-alcoholic fatty liver disease histological parameters, and can potentially identify patients with non-alcoholic steatohepatitis and cirrhosis.
引用
收藏
页码:1065 / 1073
页数:9
相关论文
共 50 条
  • [1] Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
    Eddowes, P. J.
    McDonald, N.
    Davies, N.
    Semple, S. I. K.
    Kendall, T. J.
    Hodson, J.
    Newsome, P. N.
    Flintham, R. B.
    Wesolowski, R.
    Blake, L.
    Duarte, R. V.
    Kelly, C. J.
    Herlihy, A. H.
    Kelly, M. D.
    Olliff, S. P.
    Hubscher, S. G.
    Fallowfield, J. A.
    Hirschfield, G. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 631 - 644
  • [2] Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy
    Tovo, Cristiane Valle
    de Mattos, Angelo Zambam
    Coral, Gabriela Perdomo
    Branco, Fernanda Schild
    Suwa, Eiji
    de Mattos, Angelo Alves
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4432 - 4439
  • [3] Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Honda, Yasushi
    Yoneda, Masato
    Imajo, Kento
    Nakajima, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 14
  • [4] Non-alcoholic fatty liver disease: A poorly known pandemic
    Augustin, Salvador
    Graupera, Isabel
    Caballeria, Juan
    MEDICINA CLINICA, 2017, 149 (12): : 542 - 548
  • [5] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [6] Assessment of transient elastography in Japanese patients with non-alcoholic fatty liver disease
    Seki, Kojiro
    Shima, Toshihide
    Oya, Hirohisa
    Mitsumoto, Yasuhide
    Mizuno, Masayuki
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2017, 47 (09) : 882 - 889
  • [7] The role of elastography in non-alcoholic fatty liver disease
    Liguori, Antonio
    Ainora, Maria E.
    Riccardi, Laura
    De Matthaeis, Nicoletta
    Pizzolante, Fabrizio
    Gasbarrini, Antonio
    Zocco, Maria A.
    Grieco, Antonio
    Rapaccini, Gianludovico
    Miele, Luca
    MINERVA GASTROENTEROLOGY, 2021, 67 (02): : 164 - 170
  • [8] Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques
    Cobbold, Jeremy F. L.
    Patel, Dhupal
    Taylor-Robinson, Simon D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (08) : 1281 - 1292
  • [9] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [10] Treatment of Non-Alcoholic Fatty Liver Disease
    Dyson, Jessica
    Day, Chris
    DIGESTIVE DISEASES, 2014, 32 (05) : 597 - 604